Clinical Trial Results:
A phase III, randomized, comparative, open-label study of intravenous iron oligosaccharide (Monofer®) administered by infusions or repeated bolus injections in comparison with oral iron sulphate in inflammatory bowel disease subjects with iron deficiency anaemia
Summary
|
|
EudraCT number |
2009-012544-16 |
Trial protocol |
GB DK AT HU |
Global completion date |
30 Jul 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
30 Mar 2016
|
First version publication date |
30 Mar 2016
|
Other versions |
|
Summary report(s) |
A phase III, randomised, comparative, open-label study of intravenous iron isomaltoside 1000 (Monofer®) administered by infusions or repeated bolus injections in comparison with oral iron sulphate in |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.